Abstract 4363130: Multi-Omic Analyses Identifies Novel Candidate Molecular Drivers of Coronary Artery Calcification

Y Yugene Guo (Mass General Brigham, Somerville, Massachusetts, United States) S Sujin Lee M Maria Murach (University of Virginia, Charlottesville, Virginia, United States) K Kuldeep Singh J Jose Verdezoto (University of Virginia, Charlottesville, Virginia, United States) G Gaelle Auguste F François Aguet K Kristin Ardlie (Broad Institute of MIT and Harvard, Cambridge, MA, USA.) C Clary Clish X Xiuqing Guo C Craig Johnson L Lifang Hou Y Yongmei Liu (Division of Cardiology, Department of Medicine, School of Medicine, Duke University, Durham, NC, USA.) A Alex Reiner (Department of Epidemiology, University of Washington, Seattle, WA, USA.) R Ryan Irvin (UNIVERSITY ALABAMA BIRMINGHAM, Birmiham, Alabama, United States) U Usman Tahir (Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States) E Eric Boerwinkle D Daniel Cruz M Myriam Fornage N Nora Franceschini (University of North Carolina, Chapel Hill, NC, USA.) N Nancy Heard-Costa (Chobanian & Avedisian School of Medicine, Boston University, Boston, MA, USA.) Y Yun Li L Laura Raffield E Edwin Silverman (Mass General Brigham, Somerville, Massachusetts, United States) M Matthew Budoff (The Lundquist Institute, Torrance, California, United States) R Robert Gerszten D Donald Lloyd-Jones (Framingham Center for Population and Prevention Science, Framingham, MA) P Patricia Peyser (University of Michigan, Ann Arbor, Michigan, United States) W Wendy Post (JOHNS HOPKINS UNIVERSITY, Baltimore, Maryland, United States) R Ramachandran Vasan (UT Health San Antonio, San Antonio, Texas, United States) S Stephen Rich J Jerome Rotter (The Lundquist Institute, Torrance, California, United States) K Kent Taylor (The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States) P Paul de Vries (University of Texas Health at Houston, Houston, TX, USA.) C Clint Miller (University Of Virginia, Charlottesvle, Virginia, United States) R Rajeev Malhotra (Department of Medicine, Cardiology Division, Massachusetts General Brigham Heart and Vascular Institute, Boston (I.L., T.I., L.P.C., I.G., J.C., R.M., G.D.L.).)

Abstract

Background: Coronary artery calcification (CAC) is a strong independent predictor of CAD, yet the underlying molecular mechanisms remain incompletely understood. We aimed to identify novel molecular mediators of CAC using a multi-omics approach, with a focus on those proteins likely to have a direct effect on the vasculature. Methods: We conducted a proteome-wide association study in a pooled cohort of CARDIA, MESA, and FHS participants with Olink plasma proteomic profiling and CT-based CAC scoring (n = 6468). We identified proteins independently associated with CAC after adjusting for established CAC risk factors (age, sex, BMI, hypertension, diabetes mellitus, chronic kidney disease, statin use, ethnicity, and smoking status). These proteins were further evaluated for their ability to predict myocardial infarction in an expanded cohort of MESA, FHS, and UK Biobank participants (n=57,198). To prioritize proteins involved in vascular smooth muscle cell (VSMC)-mediated calcification, we identified proteins with differential gene expression in human VSMCs cultured in osteogenic media versus normal media. Causal effects of these proteins were evaluated using Two-sample Mendelian randomization (using inverse variance weighting (IVW), Egger and maximum likelihood) with plasma proteomics GWAS summary statistics as exposures and the largest existing CAC GWAS meta-analysis summary statistics as the outcome. Results: Of 2,805 proteins measured, 365 were independently associated with CAC scores (FDR p<0.05), and enriched in pathways related to inflammatory response, immune cell signaling, ECM organization, and key vascular cell signaling pathways (Fig. 1). Among these, 216 proteins also independently predicted myocardial infarction. Transcriptomic analysis in human VSMCs identified 43 genes upregulated under osteogenic conditions, of which 8 demonstrated evidence of causal effects on CAC via Mendelian Randomization. These proteins are implicated in pathways related to immune cell signaling, bone signaling, and metabolic regulation. Conclusion: Using a multi-omics strategy integrating proteomic, transcriptomic, and genomic data, we identified several novel candidate molecular drivers of CAC with supporting evidence for their roles in myocardial infarction and VSMC osteogenic phenotypic modulation. These findings provide promising avenues for future mechanistic studies in vascular calcification.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (36)

Y

Yugene Guo

Mass General Brigham, Somerville, Massachusetts, United States

S

Sujin Lee

M

Maria Murach

University of Virginia, Charlottesville, Virginia, United States

K

Kuldeep Singh

J

Jose Verdezoto

University of Virginia, Charlottesville, Virginia, United States

G

Gaelle Auguste

F

François Aguet

K

Kristin Ardlie

Broad Institute of MIT and Harvard, Cambridge, MA, USA.

C

Clary Clish

X

Xiuqing Guo

C

Craig Johnson

L

Lifang Hou

Y

Yongmei Liu

Division of Cardiology, Department of Medicine, School of Medicine, Duke University, Durham, NC, USA.

A

Alex Reiner

Department of Epidemiology, University of Washington, Seattle, WA, USA.

R

Ryan Irvin

UNIVERSITY ALABAMA BIRMINGHAM, Birmiham, Alabama, United States

U

Usman Tahir

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

E

Eric Boerwinkle

D

Daniel Cruz

M

Myriam Fornage

N

Nora Franceschini

University of North Carolina, Chapel Hill, NC, USA.

N

Nancy Heard-Costa

Chobanian & Avedisian School of Medicine, Boston University, Boston, MA, USA.

Y

Yun Li

L

Laura Raffield

E

Edwin Silverman

Mass General Brigham, Somerville, Massachusetts, United States

M

Matthew Budoff

The Lundquist Institute, Torrance, California, United States

R

Robert Gerszten

D

Donald Lloyd-Jones

Framingham Center for Population and Prevention Science, Framingham, MA

P

Patricia Peyser

University of Michigan, Ann Arbor, Michigan, United States

W

Wendy Post

JOHNS HOPKINS UNIVERSITY, Baltimore, Maryland, United States

R

Ramachandran Vasan

UT Health San Antonio, San Antonio, Texas, United States

S

Stephen Rich

J

Jerome Rotter

The Lundquist Institute, Torrance, California, United States

K

Kent Taylor

The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States

P

Paul de Vries

University of Texas Health at Houston, Houston, TX, USA.

C

Clint Miller

University Of Virginia, Charlottesvle, Virginia, United States

R

Rajeev Malhotra

Department of Medicine, Cardiology Division, Massachusetts General Brigham Heart and Vascular Institute, Boston (I.L., T.I., L.P.C., I.G., J.C., R.M., G.D.L.).